Targeting of Drugs 6 Strategies for Stealth Therapeutic Systems [Hardcover]

Proceedings of a NATO ASI held in Cape Sounion Beach, Greece, June 24-July 5, 1997Interactions between Blood Components and Artificial Surfaces; K.D. Caldwell. The Mononuclear Phagocyte System: Features Relevant to Interactions with Liposomes; S. Gordon. StealthTM Therapeutic Systems: Rationale and Strategies; D.J.A. Crommelin, G. Storm. Long Circulating Liposomes: Evolution of the Concept; G. Gregoriadis. Sterically Stabilized Immunoliposomes: Formulations for Delivery of Drugs and Genes to Tumor Cells in Vivo; J.W. Park, et al. Pegylation of Liposomes in Cell-Specific Targeting: It Does Not Always Make Sense; G.L. Scherphof, et al.. StealthTM Liposomes for the Targeting of Drugs in Cancer Therapy; T.M. Allen, et al. StealthTM Liposomes as Carriers of Doxorubicin; D. Goren, et al. Liposome-Mediated Delivery of Retinoids; K. Mehta, et al. Applications of Liposome Technology to Overcome Multidrug Resistance in Solid Tumors; R. Krishna, L.D. Mayer. Use of Radiolabeled Liposomes for PEG-Liposome-Based Drug Targeting and Diagnostic Imaging Applications; W.T. Phillips. Diagnostic and Therapeutic Targeting of Infectious and Inflammatory Diseases Using Sterically Stabilized Liposomes; G. Storm, et al. Biologically Active Ligand-Bearing Polymer-Grafted Liposomes; S. Zalipsky, et al. 11 Additional Articles. Index.